Omnicell, Inc. (OMCL)
NASDAQ: OMCL · IEX Real-Time Price · USD
27.52
0.00 (0.00%)
At close: Jul 19, 2024, 4:00 PM
27.42
-0.10 (-0.36%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Omnicell Employees
Omnicell had 3,650 employees as of December 31, 2023. The number of employees decreased by 580 or -13.71% compared to the previous year.
Employees
3,650
Change (1Y)
-580
Growth (1Y)
-13.71%
Revenue / Employee
$302,092
Profits / Employee
-$5,766
Market Cap
1.26B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 3,650 | -580 | -13.71% |
Dec 31, 2022 | 4,230 | 430 | 11.32% |
Dec 31, 2021 | 3,800 | 940 | 32.87% |
Dec 31, 2020 | 2,860 | 160 | 5.93% |
Dec 31, 2019 | 2,700 | 220 | 8.87% |
Dec 31, 2018 | 2,480 | 130 | 5.53% |
Dec 31, 2017 | 2,350 | -94 | -3.85% |
Dec 31, 2016 | 2,444 | 993 | 68.44% |
Dec 31, 2015 | 1,451 | 215 | 17.39% |
Dec 31, 2014 | 1,236 | 102 | 8.99% |
Dec 31, 2013 | 1,134 | 45 | 4.13% |
Dec 31, 2012 | 1,089 | 316 | 40.88% |
Dec 31, 2011 | 773 | 20 | 2.66% |
Dec 31, 2010 | 753 | 0 | - |
Dec 31, 2009 | 753 | -91 | -10.78% |
Dec 31, 2008 | 844 | 38 | 4.71% |
Dec 31, 2007 | 806 | 180 | 28.75% |
Dec 31, 2006 | 626 | 112 | 21.79% |
Dec 31, 2005 | 514 | 26 | 5.33% |
Dec 31, 2004 | 488 | 56 | 12.96% |
Dec 31, 2003 | 432 | 82 | 23.43% |
Dec 31, 2002 | 350 | -25 | -6.67% |
Dec 31, 2001 | 375 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
AtriCure | 1,050 |
Establishment Labs Holdings | 908 |
Maravai LifeSciences Holdings | 650 |
Gyre Therapeutics | 593 |
Immatics | 535 |
Sana Biotechnology | 328 |
Xencor | 280 |
Ardelyx | 267 |
OMCL News
- 6 days ago - Omnicell to Release Second Quarter 2024 Financial Results on August 1, 2024 - Business Wire
- 2 months ago - Omnicell Supports Global Charity Mercy Ships with Pharmacy Technology Donation - Business Wire
- 2 months ago - Omnicell to Present at the BofA Securities 2024 Health Care Conference - Business Wire
- 2 months ago - Omnicell Announces First Quarter 2024 Results - Business Wire
- 3 months ago - Omnicell Announces XT Amplify - Business Wire
- 3 months ago - Omnicell to Release First Quarter 2024 Financial Results on May 2, 2024 - Business Wire
- 4 months ago - Omnicell to Present at the virtual KeyBanc Annual Life Sciences & MedTech Investor Forum - Business Wire
- 5 months ago - Omnicell Announces Fiscal Year and Fourth Quarter 2023 Results - Business Wire